Introduction Antiphospholipid syndrome (APS) is an autoimmune disease characterised by obstetric morbidity and recurrent ...

Patients with thrombotic antiphospholipid syndrome are better treated with a vitamin K antagonist, such as warfarin, rather than a direct oral anticoagulant (DOAC), a new systematic review and ...

Most clots seen in the antiphospholipid syndrome (APS) are venous; however, a proportion of clots can be arterial, leading to significant morbidity and mortality. Furthermore, arterial vascular ...

Targeting glycolysis can help lower neutrophil extracellular trap formation in antiphospholipid syndrome. Neutrophils are an important type of white blood cell that help your immune system fight ...

Antiphospholipid syndrome (APS) is an autoimmune disorder characterised by the persistent presence of antiphospholipid antibodies (aPL), which significantly increase the risk of thrombosis and adverse ...

A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients.

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Preventing the first thrombosis, and better circumvention of the second, are currently the biggest ...

Antiphospholipid syndrome, also known as APS, is an autoimmune disease that sits at the intersection of inflammation and blood clotting. Antiphospholipid syndrome is best known for increasing the risk ...

Investigators from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) presented new research findings in antiphospholipid syndrome (APS) at the ...

Please provide your email address to receive an email when new articles are posted on . “CATCR-T cells are precision cellular therapies designed to selectively ...

A 47-year-old woman in Germany had spent more than a decade battling three severe autoimmune diseases at once: autoimmune ...